Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000654998 | SCV000721314 | benign | not provided | 2021-01-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001473620 | SCV001677774 | likely benign | RASopathy | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002467930 | SCV002763272 | likely benign | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002467929 | SCV002763273 | likely benign | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing | ||
Fulgent Genetics, |
RCV002483689 | SCV002796739 | likely benign | Fibromatosis, gingival, 1; Noonan syndrome 4 | 2022-01-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917921 | SCV004728029 | likely benign | SOS1-related disorder | 2021-08-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |